These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11093885)

  • 1. [Aplasia after azathioprine administration: role of the thiopurine methyltransferase genetic polymorphism].
    Corominas H; Domènech M; González-Juan D; González-Suárez B; Díaz C; Pujol J; Vázquez G; Baiget M
    Med Clin (Barc); 2000 Sep; 115(8):299-301. PubMed ID: 11093885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
    Colombel JF; Ferrari N; Debuysere H; Marteau P; Gendre JP; Bonaz B; Soulé JC; Modigliani R; Touze Y; Catala P; Libersa C; Broly F
    Gastroenterology; 2000 Jun; 118(6):1025-30. PubMed ID: 10833476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
    Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease].
    Tárnok A
    Orv Hetil; 2019 Feb; 160(5):179-185. PubMed ID: 30686035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
    Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
    Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
    Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
    Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPMT*26 (208F-->L), a novel mutation detected in a Chinese.
    Kham SK; Soh CK; Aw DC; Yeoh AE
    Br J Clin Pharmacol; 2009 Jul; 68(1):120-3. PubMed ID: 19660010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease.
    Regueiro M; Mardini H
    J Clin Gastroenterol; 2002 Sep; 35(3):240-4. PubMed ID: 12192200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
    Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
    Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression.
    Leung M; Piatkov I; Rochester C; Boyages SC; Leong RW
    Intern Med J; 2009 Feb; 39(2):121-6. PubMed ID: 19356188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
    Snow JL; Gibson LE
    Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPMT in the treatment of Crohn's disease with azathioprine.
    Lennard L
    Gut; 2002 Aug; 51(2):143-6. PubMed ID: 12117866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure red cell aplasia due to azathioprine therapy for Crohn's disease.
    Kamath N; Pai CG; Deltombe T
    Indian J Pharmacol; 2016; 48(1):86-7. PubMed ID: 26997730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.
    Perri D; Cole DE; Friedman O; Piliotis E; Mintz S; Adhikari NK
    Eur Respir J; 2007 Nov; 30(5):1014-7. PubMed ID: 17978158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.
    Davavala SK; Desai DC; Abraham P; Ashavaid T; Joshi A; Gupta T
    Indian J Gastroenterol; 2014 Jan; 33(1):41-5. PubMed ID: 23996738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic polymorphisms of thiopurine methyltransferase and incidence of adverse events in patients with medical indication of azathioprine].
    Buhl MA; Gómez G; Collado MV; Oddo EM; Khoury M; Azurmendi PJ; Sarano J
    Medicina (B Aires); 2018; 78(2):65-70. PubMed ID: 29659353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.